Allo-HCT regimens with low toxicity needed in older patients with acute myeloid leukaemia--Authors' reply

Lancet Oncol. 2016 Jan;17(1):e1-2. doi: 10.1016/S1470-2045(15)00586-0. Epub 2015 Dec 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Busulfan / administration & dosage*
  • Cyclophosphamide / administration & dosage*
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Induction Chemotherapy*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / surgery*
  • Male
  • Transplantation Conditioning*
  • Vidarabine / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Cyclophosphamide
  • Vidarabine
  • Busulfan